Presented by
Management Forum
Additional Risk Minimization Measures (aRMMs) and Their Effectiveness In-house Training
Delve into the world of additional Risk Minimization Measures (aRMMs) and explore everything from the regulatory framework surrounding aRMMs to their impact on patient safety and healthcare outcomes.
- Format: Live online
- CPD: 3 hours for your records
- Certificate of completion
You may also be interested in...
- Signal Detection and Regulatory Expectations
- A Practical Guide to Producing and Maintaining the PSMF
- A Practical Guide to Writing Risk Management Plans (RMPs)
- AI in Pharmacovigilance
- Additional Risk Minimization Measures (aRMMs) and Their Effectiveness
- Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP)
- Clinical & Post-Marketing Safety
- Literature Searching in Drug Safety
- Signal Detection: A Comprehensive Introduction
Course overview
This course delves into the world of additional Risk Minimisation Measures (aRMMs), providing a thorough understanding of their development, implementation and assessment. Participants will explore the regulatory framework surrounding aRMMs, learn how to design effective risk minimisation strategies and evaluate their impact on patient safety and healthcare outcomes. This course combines theoretical knowledge with practical insights, enabling attendees to enhance their skills in managing and monitoring aRMMs in their organisations.
Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.
Benefits of attending
- Gain in-depth knowledge of aRMMs, including their purpose, development and regulatory requirements
- Learn how to create and implement effective risk minimisation strategies tailored to specific safety concerns
- Discover methods for assessing the effectiveness of aRMMs and making data-driven improvements
- Stay informed about the latest regulatory guidelines and best practices for aRMMs
- Explore the ethical aspects of implementing aRMMs and ensuring patient safety
Who should attend?
- Pharmacovigilance specialists
- Drug Safety Officers
- Regulatory affairs professionals
- Clinical research associates
- Medical affairs personnel
- Risk management professionals
- Healthcare Quality Assurance specialists
This course will cover:
Introduction to aRMMs
- Overview of additional Risk Minimisation Measures
- Importance and objectives of aRMMs and their effectiveness evaluation
Understanding global regulatory guidelines for aRMMs
- Key regulatory requirements and compliance
- How new safety data affect decisions and benefit-risk balance
Principles of designing risk minimization strategies
- Designing Effective aRMMs
- Case study on aRMM implementations
Practical approaches to implementing aRMMs
- Implementation Strategies: Engaging stakeholders and ensuring adherence
- Real-world scenarios and problem-solving
Methods for monitoring and assessing the impact of aRMMs
- Data collection, analysis, and reporting
- Ethics in aRMM Implementation
United Kingdom
- Bionical Emas
- BionicalEmas
- Milpharm Ltd
- Pharmacosmos
Czech Republic
- ZENTIVA GROUP AS
Denmark
- 2care4 Generics ApS
France
- Amgen France
Italy
- Clinpharma SRL
Portugal
- NOVA Medical School
Spain
- Esteve Pharmaceuticals
Switzerland
- Vifor Pharma
Run Additional Risk Minimization Measures (aRMMs) and Their Effectiveness Live online for your team
Half-day
Typical duration
Pricing from:
- GBP 350
- Per attendee, based on 10 attendees
- Course tailored to your requirements
- At your choice of location, or online
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
